These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 30371597
1. Distinct Imaging Characteristics of Different Metastases From Primary Prostate Adenocarcinoma and Rectal Carcinoid Tumor on 18F-Fluciclovine and 68Ga-DOTATATE PET/CT. Bosserman AJ, Dai D, Lu Y. Clin Nucl Med; 2019 Jan; 44(1):83-84. PubMed ID: 30371597 [Abstract] [Full Text] [Related]
2. Diagnostic performance of 18F-fluciclovine PET/CT for regional lymph node metastases in patients with primary prostate cancer: a multicenter phase II clinical trial. Suzuki H, Jinnouchi S, Kaji Y, Kishida T, Kinoshita H, Yamaguchi S, Tobe T, Okamura T, Kawakita M, Furukawa J, Otaka A, Kakehi Y. Jpn J Clin Oncol; 2019 Sep 01; 49(9):803-811. PubMed ID: 31095314 [Abstract] [Full Text] [Related]
3. 18F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients. Selnæs KM, Krüger-Stokke B, Elschot M, Willoch F, Størkersen Ø, Sandsmark E, Moestue SA, Tessem MB, Halvorsen D, Kjøbli E, Angelsen A, Langørgen S, Bertilsson H, Bathen TF. Eur Radiol; 2018 Aug 01; 28(8):3151-3159. PubMed ID: 29294158 [Abstract] [Full Text] [Related]
4. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers. Ulaner GA, Goldman DA, Gönen M, Pham H, Castillo R, Lyashchenko SK, Lewis JS, Dang C. J Nucl Med; 2016 Sep 01; 57(9):1350-6. PubMed ID: 26940766 [Abstract] [Full Text] [Related]
5. Superscan 18F-Fluciclovine PET/CT of PSA-Negative Prostate Cancer Bone Metastases. Chen B, Macapinlac HA, Lu Y. Clin Nucl Med; 2019 Apr 01; 44(4):337-338. PubMed ID: 30688749 [Abstract] [Full Text] [Related]
6. Metastasized 18F-DCFPyL-Negative Prostatic Adenocarcinoma Without Neuroendocrine Differentiation. Broos WAM, Kocken M, van der Zant FM, Knol RJJ, Wondergem M. Clin Nucl Med; 2018 Feb 01; 43(2):120-122. PubMed ID: 29261618 [Abstract] [Full Text] [Related]
7. The "Ultimate Triple PET": 68Ga-DOTATATE, 18F-FDG, and 18F-Fluciclovine PET/CT Findings in a Single Patient With Metastatic Abdominal Carcinoid and Prostate Cancer. McClenathan M, Peacock JG. Clin Nucl Med; 2022 Feb 01; 47(2):e161-e164. PubMed ID: 34392283 [Abstract] [Full Text] [Related]
8. Multifocal Small Bowel Carcinoid: Evaluation by 68Ga-DOTATATE PET. Clark M, Nathan M, Broski SM. Clin Nucl Med; 2019 Apr 01; 44(4):e308-e310. PubMed ID: 30762820 [Abstract] [Full Text] [Related]
9. Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial. Schreibmann E, Schuster DM, Rossi PJ, Shelton J, Cooper S, Jani AB. Int J Radiat Oncol Biol Phys; 2016 Sep 01; 96(1):206-13. PubMed ID: 27511856 [Abstract] [Full Text] [Related]
10. 68Ga-DOTATATE in Benign Prostate Hyperplasia. Wang J. Clin Nucl Med; 2019 Mar 01; 44(3):249-250. PubMed ID: 30624277 [Abstract] [Full Text] [Related]
11. Diagnostic and Therapeutic Uptake of Intrathyroid Metastasis of Midgut Neuroendocrine Tumor on 68Ga-DOTANOC PET/CT and 177Lu-DOTATATE Imaging. Vija Racaru L, Sinigaglia M, Fontaine S, DʼAure D, Courbon F, Dierickx L. Clin Nucl Med; 2019 Jul 01; 44(7):e445-e448. PubMed ID: 31021912 [Abstract] [Full Text] [Related]
13. Laparoscopic Port-Site Metastasis From Prostate Cancer on 18F-Fluciclovine PET/CT. Tran G, Parrinello D, Dalal I. Clin Nucl Med; 2021 May 01; 46(5):e279-e281. PubMed ID: 33208626 [Abstract] [Full Text] [Related]
14. Prospective Clinical Trial of 18F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant Therapy in Invasive Ductal and Invasive Lobular Breast Cancers. Ulaner GA, Goldman DA, Corben A, Lyashchenko SK, Gönen M, Lewis JS, Dickler M. J Nucl Med; 2017 Jul 01; 58(7):1037-1042. PubMed ID: 27856630 [Abstract] [Full Text] [Related]
15. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors? Has Simsek D, Kuyumcu S, Turkmen C, Sanlı Y, Aykan F, Unal S, Adalet I. J Nucl Med; 2014 Nov 01; 55(11):1811-7. PubMed ID: 25315243 [Abstract] [Full Text] [Related]
16. [18F]Fluciclovine Positron Emission Tomography/Computerized Tomography for Preoperative Staging in Patients with Intermediate to High Risk Primary Prostate Cancer. Alemozaffar M, Akintayo AA, Abiodun-Ojo OA, Patil D, Saeed F, Huang Y, Osunkoya AO, Goodman MM, Sanda M, Schuster DM. J Urol; 2020 Oct 01; 204(4):734-740. PubMed ID: 32347780 [Abstract] [Full Text] [Related]
17. Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using 18F-Fluciclovine PET/CT. Miller MP, Kostakoglu L, Pryma D, Yu JQ, Chau A, Perlman E, Clarke B, Rosen D, Ward P. J Nucl Med; 2017 Oct 01; 58(10):1596-1602. PubMed ID: 28385791 [Abstract] [Full Text] [Related]
18. Imaging Characteristics of Coexisting Primary Pulmonary Carcinoid Tumor and Multiple Myeloma on 18F-FDG and 68Ga-DOTATATE PET/CT. Lu Y. Clin Nucl Med; 2019 Nov 01; 44(11):914-915. PubMed ID: 31306189 [Abstract] [Full Text] [Related]
20. Is There Any Role for 18F-Fluciclovine PET/CT in the Presence of Undetectable PSA in Prostate Cancer Patients After Definitive Treatment? Teyateeti A, Teyateeti A, Macapinlac HA, Lu Y. Clin Nucl Med; 2020 Sep 01; 45(9):672-678. PubMed ID: 32604105 [Abstract] [Full Text] [Related] Page: [Next] [New Search]